Leif Bergsagel, MD

Accepting PhD Students

  • 22604 Citations
  • 81 h-Index
1984 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Plasma Cells Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Tumors Chemical Compounds
Cell Line Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1997 2020

Monoclonal Gammopathy of Undetermined Significance
Plasma Cells
Multiple Myeloma
Mutation
Bone Neoplasms
Multiple Myeloma
Oncolytic Virotherapy
Clonal Evolution
Vesicular Stomatitis
Research
Multiple Myeloma
Therapeutics
Cell Line
Clustered Regularly Interspaced Short Palindromic Repeats
Polyploidy
Multiple Myeloma
Disease Progression
Polyploidy
Mutation
Drug Resistance

Research Output 1984 2019

1 Citation (Scopus)

Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4

Zhu, Y. X., Shi, C. X., Bruins, L. A., Wang, X., Riggs, D. L., Porter, B., Ahmann, J. M., de Campos, C. B., Braggio, E. D., Bergsagel, P. L. & Stewart, A. K., Feb 1 2019, In : Blood cancer journal. 9, 2, 19.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Cell Line
Down-Regulation
lenalidomide
Sequence Deletion

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model

Thirukkumaran, C. M., Shi, Z. Q., Nuovo, G. J., Luider, J., Kopciuk, K. A., Dong, Y., Mostafa, A. A., Thakur, S., Gratton, K., Yang, A., Chin, A. C., Coffey, M. C., Jimenez-Zepeda, V. H., Stewart, D., Chesi, M., Bergsagel, P. L. & Morris, D., Mar 12 2019, In : Blood advances. 3, 5, p. 797-812 16 p.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Immunotherapy
Survival
Neoplasms
Therapeutics

Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies

Kumar, S. K., Larson, D. R., Dispenzieri, A., Therneau, T. M., Murray, D. L., Bergsagel, P. L., Kyle, R. A. & Rajkumar, S. V., Jun 1 2019, In : Blood cancer journal. 9, 6, 49.

Research output: Contribution to journalArticle

Open Access
Paraproteinemias
Monoclonal Gammopathy of Undetermined Significance
Light
Serum
Plasma Cells

Antigen-mediated regulation in monoclonal gammopathies and myeloma

Nair, S., Sng, J., Boddupalli, C. S., Seckinger, A., Chesi, M., Fulciniti, M., Zhang, L., Rauniyar, N., Lopez, M., Neparidze, N., Parker, T., Munshi, N. C., Sexton, R., Barlogie, B., Orlowski, R., Bergsagel, P. L., Hose, D., Flavell, R. A., Mistry, P. K., Meffre, E. & 1 othersDhodapkar, M. V., Apr 19 2018, In : JCI insight. 3, 8

Research output: Contribution to journalArticle

Open Access
Paraproteinemias
Antigens
Gaucher Disease
Plasma Cells
Multiple Myeloma

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cyclophosphamide
Dexamethasone
Safety
Peripheral Nervous System Diseases